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It is generally believed that diseases caused by oxidative stress should be treated with antioxidants. However, clinical trials with
such antioxidants as ascorbic acid and vitamin E, failed to produce the expected beneﬁcial results. On the other hand, important
biomolecules can be modiﬁed by the introduction of oxygen atoms by means of non-oxidative hydroxyl radicals. In addition,
hydroxyl radicals can reduce disulﬁde bonds in proteins, speciﬁcally ﬁbrinogen, resulting in their unfolding and scrambled
refoldingintoabnormalspatialconﬁgurations.Consequencesofthisreactionareobservedinmanydiseasessuchasatherosclerosis,
cancer and neurological disorders, and can be prevented by the action of non-reducing substances. Moreover, many therapeutic
substances, traditionally classiﬁed as antioxidants, accept electrons and thus are eﬀective oxidants. It is described in this paper
that hydroxyl radicals can be generated by ferric ions without any oxidizing agent. In view of the well-known damaging eﬀect
of poorly chelated iron in the human body, numerous natural products containing iron binding agents can be essential in the
maintenance of human health. However, beneﬁcial eﬀects of the great number of phytochemicals that are endowed with hydroxyl
radical scavenging and/or iron chelating activities should not be considered as a proof for oxidative stress.
1.Introduction
It is commonly believed that the in vivo damage of
biomolecules is initiated by reactive oxygen species (ROS)
in a process known as oxidative stress. However, oxidation
reactioninbiologicalsystemsmayalsooccurviaanonradical
pathway, for example, by hydrogen peroxide. In such cases,
the products of its action are molecules that are enriched
in one or more oxygen atoms that are generally considered
to be markers of oxidative stress. Yet mere presence of extra
oxygen does not tell us whether a given product is generated
by a single- (free radical) or two-electron oxidation reaction.
It should be emphasized that, according to the concept of
oxidative stress, peroxidation and degradation of vulnerable
biological molecules is caused by oxygen-centered radicals
generated, in turn, by excessive blood oxygenation. However,
this conclusion is based on studies of ischemia/reperfusion
cases in which periods of prolonged hypoxia are followed by
a sudden supply of oxygen. For example, in patients with
extracorporeal circulation the appearance of lipid and/or
nucleic acids oxidation products is accepted as signs of
oxidative stress. However, a very important fact is being
neglected, namely, that the most biologically active hydroxyl
radicals are being predominantly formed during the period
of ischemia in which oxygen is in short supply.
The uncritical acceptance of the fact that the presence
of additional oxygen atom(s) in biomolecules and in their
degradation products is a sign of oxidation led to a mis-
leading deﬁnition of what is an antioxidant. According to
principles of electrochemistry antioxidant must be endowed
with a reductive property, but except ascorbic acid (vitamin
C)andglutathione,thereareveryfewnaturalsubstancesthat
havereducingproperties[1,2].Therefore,itisnotsurprising
thatascorbicacidhasnotonlyfailedtopreventconsequences
of oxidative stress [3] but on the contrary exhibited delete-
rious eﬀects [4]. These facts present a paradox exempliﬁed
by a failure to demonstrate a signiﬁcant eﬀect of antioxidant
therapies in diseases believed to be associated with oxidative
stress, for example, atherosclerosis [5] .S e v e r a la t t e m p t sw e r e
made to explain this problem in a series of publications [6–
8]. Another line of evidence showing the lack of beneﬁts
from the use of antioxidants is their ineﬀectiveness in the
prevention or treatment of hypertension [9]. By contrast, a
diet rich in fruits and vegetables and whole grains protects2 Oxidative Medicine and Cellular Longevity
cardiovascular system and lowers blood pressure by reducing
free radical stress [10]. These important, albeit controversial,
issues are being reviewed in this paper.
2. Generationand Properties of
HydroxylRadicals
In living organisms there are two major reactive oxygen
species, superoxide radical and hydroxyl radical that are
being continuously formed in a process of reduction of
o x y g e nt ow a t e r .I nt h eH a b e r - W e i s sr e a c t i o nh y d r o x y l
radicals are generated in the presence of hydrogen peroxide
and iron ions. The ﬁrst step involves reduction of ferric into
ferrous ion:
Fe3++
•O
−
2 −→ Fe2+ +O 2. (1)
The second step is the Fenton reaction:
Fe2+ +H 2O2 −→ Fe3+ +OH
− +
•OH. (2)
The requirement of hydrogen peroxide in the Fenton
reaction led to the misleading concept of oxidative stress that
ignores the fact that hydroxyl radical (•OH), known to be
the most biologically active free radical, is formed in vivo
under hypoxic conditions [11]. Moreover, this free radical
can be generated in vitro under the reducing condition in the
presenceofascorbicacidandironions.Evenmoreintriguing
is a discovery, presented in this paper, of the generation
of hydroxyl radicals catalyzed by ferric ions without any
additional redox agent, which can be considered as a special
case of the Fenton reaction:
Fe3+ +HO
− −→ Fe2+ +•OH (3)
where one electron from the hydroxyl group of water is
transferred to the ferric ion with the formation of a divalent
iron and a hydroxyl radical.
In addition to the essential role of hypoxic/reducing con-
ditionsfortheinvivogenerationofhydroxylradicals,thereis
anotherimportant,althoughnotgenerallyrecognized,factor
namely free iron present in blood in the so called labile iron
pool [12]. It was suggested some years ago that iron therapy
might promote the formation of hydroxyl radicals thus
contributing to atherosclerosis [13, 14]. In connection with
this, it is of importance to note that excessive accumulation
of stored iron is observed in atherosclerotic lesion [15]a s
well as in brains patients with neurological diseases [16].
In his paper with 136 references, Brewer reviewed the roles
of both iron and copper in aging-related diseases [17].
More recently, another comprehensive review of the role
of iron in degenerative diseases was published [18]. The
close relationship between iron overload and pathogenesis of
chronicdiseasecanbeexplainedintermsoftheiron-induced
hydroxyl radical generation and subsequent deposition of a
ﬁbrin-like material in various organs.
2.1. Hydroxyl Radical-Induced Polymerization of Human Fib-
rinogen. Fibrinogen is the most hydrophobic blood protein
0
0.1
0.2
0.3
0.4
0.5
0.6
0 2468 1 0 1 2 14
Iron concentrations (µM)
O
p
t
i
c
a
l
d
e
n
s
i
t
y
(
6
8
0
n
m
)
0
5000
10000
15000
20000
25000
30000
35000
40000
45000
F
l
u
o
r
e
s
c
e
n
c
e
i
n
t
e
n
s
i
t
y
Optical density (680nm)
Fluorescence intensity
Figure 1: Eﬀect of iron (ferric chloride) on ﬁbrinogen aggregation,
as measured by optical density, and on hydroxyl radical generation
expressed as ﬂuorescence intensity according to Manevich et al.
(RadiatRes1997;148:580-91).Astocksolutionof1mMcoumarin-
3-carboxylic acid was diluted 1:2 with PBS, pH 7.4, and stored
at room temperature before the use. Fifty-microliter aliquots of
ferric chloride solution at various molar concentrations were added
to black plastic microplate wells containing each 100μLo ft h e
coumarin reagent. After 2 min. incubation at RT ﬂuorescence of the
hydroxylation product was measured for one second in PerkinElmer
1420MultilabelCounter at350/450nmofexcitation/emissionwave-
length.Theresultspresentedinthisﬁgureshowthattheaggregation
of ﬁbrinogen is closely related to the extent of hydroxyl radicals
generated in the system.
andthusitisveryunstableinaqueoussolutionsbeingreadily
adsorbed on various surfaces [19]. In fact, the conversion
of ﬁbrinogen to ﬁbrin by the action of thrombin renders
ﬁbrin monomers even more hydrophobic thus facilitating
their spontaneous polymerization [20]. Moreover, exposure
of puriﬁed ﬁbrinogen to the ascorbic acid/cupric ion system
results in the formation of an insoluble ﬁbrin-like precipitate
(neoﬁber) [21]. It was then serendipitously discovered that
such a dramatic modiﬁcation of ﬁbrinogen is caused by
hydroxyl radicals generated in the presence of ferric ions
without any redox agent. As can be seen in Figure 1, the
amount of precipitated ﬁbrinogen is proportional to the
number of hydroxyl radicals generated in the system.
Formation of insoluble aggregates under the inﬂuence
of hydroxyl radicals is due to a limited reduction of
intramolecular disulﬁde bridges followed by exposure of
buried hydrophobic epitopes leading to the formation
of extremely strong intermolecular bonds. Interestingly
enough, acetylation of ﬁbrinogen prior to the reaction with
hydroxyl radicals rendered it susceptible to ﬁbrinolysis [22].
It is very likely that this eﬀect of salicylates is due to the
introduction of a negative charge to the protein, thus dimin-
ishing hydrophobic interactions. An example of the eﬀect of
negative charge of sulfate groups is sulﬁtolysis of proteins
that completely unfolds their polypeptide chains and yet
maintains their complete solubility. It should be notedOxidative Medicine and Cellular Longevity 3
that ﬁbrin-like deposits, which are remarkably resistant to
proteolytic degradation, have been observed in numerous
degenerative diseases such as atherosclerosis [23, 24], cancer
[25], and diabetes [26] and in neurological disorders [27].
The same pathological conditions are characterized by exces-
sive accumulation of poorly liganded iron, thus implicating
a potential role of hydroxyl radicals in pathogenesis of these
diseases [18].
3. AntioxidantsandFreeRadical Scavengers
There is a belief that polyunsaturated fatty acids (PUFAs)
contribute to oxidative stress by providing a source of
lipid peroxides. Yet by contrast to such expectations and
according to epidemiological studies, PUFAs exert beneﬁcial
eﬀects in those diseases that are known to be associated
with free radical generation [28], and with complications of
diabetes mellitus [29]. Another example of protective eﬀect
of unsaturated fatty acids is an intriguing phenomenon of
the lack of signs of peroxidation in ringed arctic seals. These
marine mammals hunt for ﬁsh by diving for periods of time
up to 30 minutes, but, when their blood and organs are
analyzed after they emerge from water and start breathing,
no signs of oxidative stress are found [30]. Thus, it must
be concluded that PUFAs present in their body fat protect
these animals fromthe damaging consequencesof prolonged
hypoxia. This phenomenon can be explained in terms of
a hydroxyl radical scavenging capacity of double bonds of
polyunsaturated fatty acids.
Both omega-3 fatty acids and polyphenolic natural sub-
stances were shown to have protective eﬀect in Alzheimer’s
disease[31]andincancer[32]knowntobelinkedtotheper-
sistentfreeradicalstress[33],aswellindiabeticnephropathy
[34–36]. This apparent paradox can be explained by a strong
aﬃnity of hydroxyl radicals to double bonds that become
reduced to single bonds [37]. In the case of unsaturated
fatty acid (PUFA) the product formed is a hydroxy-fatty
acid, which, in the presence of molecular oxygen, is further
oxidized to aldehydes and ketones. This very important
fact is an ultimate source of confusion, since these speciﬁc
peroxidation products are considered to be markers of
oxidative stress.
In addition to the aforementioned substances, certain
biologically active agents containing phenolic rings have
the capacity to scavenge hydroxyl radicals by virtue of
aromatic hydroxylation at the orthoposition. One of such
recently discovered scavengers is resveratrol shown to have
ap r o t e c t i v ee ﬀect on ischemia-induced cerebral neuron
damage [38]. Salicylates, that belong to the class of drugs
with available orthoposition at their phenolic ring, have also
been demonstrated to protect against free radical injury
in vitro [39]a n din vivo [40]. The beneﬁcial eﬀect of
salicylic acid in diabetes mellitus was ﬁrst observed almost
100 years ago [41]. In addition, signiﬁcant reduction of a
risk of myocardial infarctions in diabetic patients has been
attributed to the hydroxyl radicals scavenging activity of
salicylates [42]. Cardiovascular consequences of excessive
hydroxyl radical production in diabetic nephropathy may
be explained in terms of their modiﬁcation of ﬁbrinogen
molecule that becomes deposited in kidneys in the form of
ﬁbrin-like aggregates [43]. Protective eﬀect against hydroxyl
radical-induced damage in biological systems has been
documented by the use of natural polyene and polyphenol
class of substances, such as ﬂavonoids, present mostly
in fruits and vegetables [44, 45]. Also, hydroxyl radicals
scavenging of double bonds present in quercetin may explain
its beneﬁcial eﬀects on the modiﬁcation of LDL molecule
[46], similarly to the action of phenolic compounds in
virgin olive [47]. Moreover, genistein, a naturally occurring
isoﬂavone of soybeans, was recently documented to be an
eﬀective hydroxyl radical scavenger by virtue of the addition
of hydroxyl groups to the double bonds of its aromatic rings
[48].
It was recently shown in an elegant paper by Attia
et al. [49] that proanthocyanidins, containing numerous
phenolic rings, have a protective role in the abatement
of doxorubicin-induced mutagenesis and cell proliferation
changesingerminalcellsofmice.Mostrecently,Acharyaand
his colleagues [50] have indicated that oxidative stress can
have positive and negative eﬀects on cellular proliferation,
growth inhibition, and/or cell death. According to these
authors determination of an in vitro antioxidant activity
does not allow to predict potential beneﬁts of plant-derived
compounds, particularly in view of the reports showing
that using antioxidants in clinical trials is associated with
increasedcancerincidences.AlongthesamelineisAfanasev’s
argument that reactive oxygen species possess important
function, namely, in molecular signaling in various patho-
physiological processes [51].
The facts presented above clearly indicate that polyphe-
nolicsubstancesareendowedwithbothanti-andprooxidant
properties. Antioxidant properties of polyphenols are based
on their ability to be oxidized by, for example, hydrogen
peroxide, to phenyl ketones (quinones) according to the
following formula:
Ph=CH–OH +H–O–O–H −→ Ph–HC=O +H–O–H. (4)
At the same time these substances can scavenge hydroxyl
radical (•OH) by virtue of their addition to double bonds
with the formation of a corresponding hydroxyl derivative:
R–CH=CH–R + •OH −→ R–CH–(OH)–CH2–R. (5)
Thus,ageneralconclusioncanbedrawnfromthesereactions
that the diﬀerence between an oxidant and antioxidant is
determined by the absence or presence of an electron in a
carbon-carbon bond in an aromatic or aliphatic compound.
It should be, however, emphasized that, in the case of
polyphenols, only those with available orthoposition in their
phenolic rings will eﬀectively scavenge hydroxyl radicals.
Therapeuticeﬀectofamixtureofproanthocyanides (Oligol),
demonstrated in in vitro tests with breast cancer cells, can
thus be explained by the presence of many such available
sites in the structure of these polyphenols [52]. However, a
particular redox property of a given polyphenol can only be
properly assessed by methods using the 2 -deoxyguanosine
assay with and without hydrogen peroxide [53].4 Oxidative Medicine and Cellular Longevity
4. Oxygen and Other Oxidants
Comparing oxidative stress to rusting of metals by oxygen
led some researchers to a false conclusion that oxygen is
deleterious to our health. It is being forgotten, however, that
modern man lives in conditions under which we breathe
less and less oxygen due to the industrial pollution and
indoor living style. It was demonstrated by the largest
epidemiological study conducted in Italy in the second half
of this century that life expectancy was best correlated with
high levels of respiratory indices, speciﬁcally vital capacity
[54]. Moreover, oxygen therapy has been shown to have
beneﬁcial eﬀect in various diseases. For example, tumor
radiosensitivityisenhancedbyincreasingtumoroxygenation
[55] that, in turn, may be explained by the eﬀect of oxygen
on the radiation-induced degradation of aggregated proteins
[56]. The positive eﬀe c to fh y p e r b a r i co x y g e ni nt u m o r
radiation therapy was reviewed in two recent papers [57, 58].
In connection with this it should be noted that powerful
oxidizing agent ozone was shown to selectively inhibit
growth of human cancer cells [59] and to enhance the
therapeutic eﬀectiveness of 5-ﬂuorouracil [60]. Contrary to
adverse eﬀects on human respiratory tract of ozone present
inthepollutedair,thisstronglyoxidizingagentwasshownto
bebeneﬁcialwhenproperlyadministeredintothecirculation
with ozone-treated blood [61]. Diabetic complications are
also believed to be associated with oxidative stress; never-
theless diabetic ulcers were successfully healed with nothing
else but a hyperbaric oxygen therapy [62]. Last but not
least is the health beneﬁcial inﬂuence of moderate exercise,
particularly in the prevention of cardiovascular disease and
consequences of aging. This eﬀect is mediated by increased
blood oxygenation, thus counterbalancing the damaging
eﬀect of hypoxia-induced generation of hydroxyl radicals.
Another class of oxidants is the substances with disulﬁde
groups in their structure that become reduced to thiols by
hydroxyl radicals [63]. One such substance is lipoic acid
(LPA) incorrectly classiﬁed as an antioxidant [64]. Reactivity
of LPA is a classical example of oxidation without the
addition of oxygen atom but just by a transfer of an electron
from a substrate to the disulﬁde bond. The non-oxygen-
assisted oxidation reaction is also exhibited by human
serum albumin (HSA). This most abundant plasma protein
contains sixteen intramolecular disulﬁde bonds that in the
process of scavenging of hydroxyl radicals become reduced,
unfolded, and aggregated. Relevant to this is a ﬁnding that
aggregation of proteins is a result of their protective action in
hypoxia/ischemic injury [65].
4.1. Selenium. Selenium is another oxidative component in
diet, the role of which in health maintenance has generally
been overlooked [66]. This metalloid is believed to be
antioxidant due to its presence in the active centers of ROS-
decomposing peroxidases and superoxide dismutases [67].
Selenium exists in soil mainly as a mineral sodium selenite
in a wide spectrum of concentrations; thus its content in
food products depends very much on a geographical area
theyaregrown.Amongstorganicformsofseleniumthemost
abundant is selenocysteine that is now recognized as the 21st
amino acid being present in about fourteen mammalian
selenoproteins [68]. However, only sodium selenite and not
the organic forms of selenium reacts rapidly with sulfhydryl
groups (SH) of proteins (P) oxidizing them to disulﬁdes
according to the following reaction:
P–[SH]2 +N a 2SeO3 −→ P–S–S–P +NaOH+SeO (6)
in which four-valent selenium is reduced to divalent oxide.
Similarly, oxidative properties of selenite can be demon-
strated by the reaction with ascorbic acid that becomes
oxidized to dehydroascorbic acid. Thus, it is obvious that
sodium selenite is an oxidant and not antioxidant as it
is generally believed [69]. Oxidative properties of selenite
have been investigated in various biological systems [70, 71].
This particular property may explain the augmentation of
the function of natural killer cells, so important for cancer
prevention and therapy [72], particularly in prostate cancer
[73, 74].
Among the medical community there is an exaggerated
concernabouttoxicityofselenium,withlittleornoattention
being paid to its chemical form used in the treatment of can-
cer [73]. Yet data on selenium toxicity and anticancer activity
was already available since 1994 [75]. In one study LD50
dose for selenite in rats was established to be 4.1mg/kg body
weight which is a thousand-fold greater than a maximum
safe dose for humans [76]. In his review the author stated
that such a dose is about 0.6mg/day, and the toxic symptoms
in the form of reversible hair loss and nails brittleness occur
at the dose of 1mg/day in a span of year or so. Importance of
selenium in biological systems and its crucial role in health
maintenance were extensively reviewed by Rayman [77]
and more recently by two other authors [78, 79]. Data on
selenium in relation to oxidative stress and health status can
also be found in a paper by Brenneisen and colleagues [80].
Recent work has demonstrated that deﬁciencies in selenium
result in increased viral pathogenicity and altered immune
responses changing benign viruses into virulent ones [81].
Beneﬁcial eﬀects of sodium selenite in human colon cancer
have also recently been reviewed [82].
5. Whole Foods or Food Supplements?
There are a number of recent publications concerning the
importance of fruit and vegetable diet in the prevention
of cardiovascular disease [83, 84]. It is well known that
plant products contain vitamins such as A, B, C, and
E, the beneﬁcial eﬀects of which have been attributed
to their antioxidant properties. However, only very few
of them are reducing agents and thus they cannot be
classiﬁed as true antioxidants, and the remaining ones
are either neutral or mild oxidants. Nevertheless, these
natural phytochemicals, particularly polyphenols, have been
shown to provide protection against many chronic diseases
by virtue of their free radical scavenging properties [85–
88]. Best known and already used in clinical practice is
resveratrol, which neutralizes hydroxyl radicals by means of
the aromatic hydroxylation reaction. Similar action against
hydroxyl radicals is exerted by ferulic acid that belongs to theOxidative Medicine and Cellular Longevity 5
family of hydroxycinnamic acid with the chemical structure
similar to curcumin [89]. Ferulic acid is found in leaves and
seeds of many plants, especially in brown rice, whole wheat,
oats, apples, artichokes, oranges, and pineapples. Curcumin
(turmeric yellow) exerts anti-inﬂammatory activity, prevents
atherosclerosis, and has protective action on brain [90].
This compound also binds cadmium and lead thus having
additional beneﬁts for human health. Likewise, extracts of
Sesamum indicum seeds were shown to scavenge hydroxyl
radicals and chelate metals [91].
Tapsell and her colleagues [92] have recently emphasized
that the whole food, and particularly a combination of
various natural food products, has a stronger health eﬀect
that any single biochemical or their combination. These
authors conclude that the public may be better served
by focusing on whole foods than on individual nutrients
included in them. Moreover, there is no complete knowledge
of food composition, and some eﬀects may result from
unidentiﬁed components. On the other hand, modiﬁcation
of certain food products, such as hydrogenation of vegetable
oils, may be more harmful than the product to be substituted
(e.g., butter) due to the generation of trans fatty acids. The
concept of food synergy becomes particularly important in
view of the lack of eﬀect of many isolated compounds shown
in clinical trials. As further emphasized by these authors, the
acceptance of this concept has the potential to reduce the
costsassociatedwithanoverdependenceonpharmacological
approaches to disease management. Another example of the
beneﬁcial eﬀect of natural food products is isoprenoids,
found in many fruits and plants including citrus (perillyl
alcohol,geraniol),sage,spearmint,nutmeg(perillylalcohol),
basil (geraniol), lemon grass (farnesol and geraniol), and
chamomile (farnesol) that are essential in the regulation
of cell proliferation, apoptosis, diﬀerentiation, and lipid
biosynthesis [93]. Flavonoids and food products containing
them have potential positive eﬀect on cardiovascular system,
most likely due to their ability to chelate iron thus inhibiting
the generation of reactive oxygen species [94].
Phenolic compounds and/or polyphenols are the impor-
tant groups of compounds occurring in plants, comprising
at least 8000 diﬀerent known structures including simple
phenols,phenolicacids,coumarinsandisocoumarins,naph-
thoquinones, xanthones, stilbenes, ﬂavonoids, and lignins.
Flavonoids, constituting the most important polyphenolic
class, are the natural substances exhibiting a wide range of
biological eﬀects including antibacterial, anti-inﬂammatory,
antiallergic, antithrombotic, and vasodilatory actions [95].
There is also a plethora of other plants and herbs that
contain polyphenolic substances that can potentially scav-
enge hydroxyl radicals and/or chelate free iron [96]. It is of
interest to note that honey contains polyphenols endowed
with antiproliferative potential [97]. In addition, Euphorbia
hirta, an annual hairy plant native to India and Australia,
has been reported to contain alkaloids, saponins, ﬂavonoids,
tannins phenolic acids, and amino acids. Traditionally, it
is used in treatment of gastrointestinal disorders, bronchial
and respiratory diseases, kidney stones, diabetes and in
conjunctivitis. It also exhibits antipyretic, analgesic, antibac-
terial, anxiolytic, anthelmintic, antifertility, antispasmodic,
Table 1: Selected phytochemicals, their sources, and beneﬁcial
health eﬀects.
Name Source Chemical class Beneﬁcial eﬀect
Ajoene Garlic Polysulﬁde Cancer, heart
diseases
Apigenin Fruits,
vegetables Flavonoid Cancer
Aronia Chokeberries Anthocyanin Cancer,
inﬂammation
Caﬀeic acid Coﬀee,
cabbage Flavonoid Inﬂammation
Capsicum Solanaceae
plant Capsaicin Pain relief
Carvone Caraway, dill Terpenoid Insecticide
Catechin Chocolate,
apples Flavan-3-ol Ischemic stroke
Chrysin Passion
ﬂower Flavones Inﬂammation
Crocin Honey Polyphenols Cold and ﬂu
Devil’s claw African plant Iridoid glycoside Inﬂammation
Ellagic acid Green tea Cyclic polyphenol Cancer
Farnesol Acacia
ﬂowers Aliphatic alcohol Chemoprevention
Ferulic acid Brown rice,
apples OH-cinnamic acid Inﬂammation
Feverfew Asteracea
plant
Sesquiterpene
lactone Headaches
Galangin Propolis Trihydroxy-
ﬂavone Antifungal
Ganoderic
acid Reishi Triterpenoid Breast cancer
Genistein Lupin,
soybeans Isoﬂavone Anticancer
GLA Borage Gamma-linolenic
acid Inﬂammation
Kaempferol Tea, broccoli Flavonoid Cancer
Naringenin Grapefruit Flavonone Hepatitis
Nasunin Egg plant Anthocyanin Antiproliferative
Quercetin Red onions Polyphenol Antihistamine,
Resveratrol Red grapes Trihydroxystilbene Anti-aging
Sabinene Caraway Bicyclin
monoterpene Hypertension,
Safranal Saﬀron Aromatic ketone Antidepressant
Salicin Willow bark Salicylic caid Antipyretic
Silybin Silymarin Polyphenol Liver diseases
Turmeric
yellow Indian plant Curcumin Diabetes, AD
antifungal, and anti-inﬂammatory activities [98]. Crocus
sativus L. (saﬀron) is widely used in folk medicine, yet
modern pharmacological studies have demonstrated that
saﬀron extract or its active constituents have anticonvulsant,
antidepressant, anti-inﬂammatory, and antitumor eﬀects, as
well as radical scavenging properties [99]. Phytochemicals,6 Oxidative Medicine and Cellular Longevity
the structure of which indicates their scavenging ability of
hydroxyl radicals, are listed in Table 1.
6. Conclusions
According to the traditional view of oxidative stress, its
pathological consequences should be counteracted and/or
prevented by antioxidants. However, clinical trials with such
potent antioxidants as vitamins C and E gave conﬂicting
if not negative results, thus questioning the concept of
oxidative mechanism of the action of oxygen centered
radicals. In fact, the most biologically reactive hydroxyl
radical causes hydroxylation of various biomolecules by
reduction of unsaturated bonds present in their structures.
Thesamereductiveprincipleoperatesinanumberofnatural
substances endowed with aromatic and/or aliphatic double
bonds making them eﬀective scavengers of hydroxyl radi-
cals. Numerous polyphenolic natural substances, commonly
considered as antioxidants, are true oxidants due to the
presence of electron acceptor groups in their molecules.
Their beneﬁcial eﬀects support the importance of oxidative
reactions in maintaining optimal health and/or preventing
degenerative diseases. Oxidation of sulfhydryl groups on the
cell surface of cancer cells by sodium selenite is another
example of the importance of oxidative processes in health
homeostasis.
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